Akebia Therapeutics Inc (STU:AX9)
€ 1.008 0.025 (2.54%) Market Cap: 213.24 Mil Enterprise Value: 214.06 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

Q4 2018 Akebia Therapeutics Inc Earnings Call Transcript

Mar 18, 2019 / 08:30PM GMT
Operator

Good day, ladies and gentlemen, and welcome to the Akebia Therapeutics Preliminary Full-Year 2018 Financial Results and Business Highlights conference call. As a reminder, this conference call is being recorded. (Operator Instructions)

I would now like to introduce your host for today's conference, [Megan]. The floor is yours.

Unidentified Company Representative

Thank you, operator. Good afternoon, and thank you for joining us to discuss our recent business progress and Akebia's preliminary full year 2018 financial results and business highlights conference call. The press release containing the company's preliminary financial results for the fourth quarter and full year 2018 was issued earlier this afternoon and is also available on our Investor Relations website. For your convenience, an audio replay of today's call will also be available on our website shortly after we conclude today's webcast.

Joining our call are John Butler, President and Chief Executive Officer; and Jason Amello, Chief Financial Officer. Rita Jain, Chief Medical Officer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot